PE20090428A1 - Un nuevo procedimiento para preparar acido 2-(3-{6-[2-(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico - Google Patents

Un nuevo procedimiento para preparar acido 2-(3-{6-[2-(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico

Info

Publication number
PE20090428A1
PE20090428A1 PE2008001109A PE2008001109A PE20090428A1 PE 20090428 A1 PE20090428 A1 PE 20090428A1 PE 2008001109 A PE2008001109 A PE 2008001109A PE 2008001109 A PE2008001109 A PE 2008001109A PE 20090428 A1 PE20090428 A1 PE 20090428A1
Authority
PE
Peru
Prior art keywords
phenyl
methyl
acid
dichlorophenyl
ethylamine
Prior art date
Application number
PE2008001109A
Other languages
English (en)
Spanish (es)
Inventor
Reda G Hanna
Matthew R Powers
Elizabeth Secord
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of PE20090428A1 publication Critical patent/PE20090428A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Catalysts (AREA)
PE2008001109A 2007-06-29 2008-06-27 Un nuevo procedimiento para preparar acido 2-(3-{6-[2-(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico PE20090428A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94725607P 2007-06-29 2007-06-29

Publications (1)

Publication Number Publication Date
PE20090428A1 true PE20090428A1 (es) 2009-05-04

Family

ID=40226759

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2008001109A PE20090428A1 (es) 2007-06-29 2008-06-27 Un nuevo procedimiento para preparar acido 2-(3-{6-[2-(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico

Country Status (11)

Country Link
US (1) US20100184979A1 (enExample)
EP (1) EP2170837B1 (enExample)
JP (1) JP2010532366A (enExample)
AR (1) AR067348A1 (enExample)
AT (1) ATE531699T1 (enExample)
CL (1) CL2008001913A1 (enExample)
PA (1) PA8786301A1 (enExample)
PE (1) PE20090428A1 (enExample)
TW (1) TW200922927A (enExample)
UY (1) UY31192A1 (enExample)
WO (1) WO2009006086A2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5833626B2 (ja) * 2010-03-23 2015-12-16 サイノファーム タイワン リミテッド ラパチニブの調製プロセス及び中間体
CN104592137B (zh) * 2014-11-04 2016-09-14 江苏大学 2,2’,2”-[1,3,5-三嗪-2,4,6-三巯基]三丙酸及其合成方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HN2005000795A (es) 2004-10-15 2010-08-19 Aventis Pharma Inc Pirimidinas como antagonistas del receptor de prostaglandina d2
GT200600457A (es) * 2005-10-13 2007-04-27 Aventis Pharma Inc Sal de fosfato dihidrogeno como antagonistas del receptor de prostaglandina d2
AR074776A1 (es) * 2008-12-18 2011-02-09 Sanofi Aventis Metodo para tratar la degeneracion macular; modulando el sistema inmunitario del paciente

Also Published As

Publication number Publication date
PA8786301A1 (es) 2009-01-23
EP2170837B1 (en) 2011-11-02
JP2010532366A (ja) 2010-10-07
EP2170837A2 (en) 2010-04-07
US20100184979A1 (en) 2010-07-22
TW200922927A (en) 2009-06-01
WO2009006086A3 (en) 2009-03-12
ATE531699T1 (de) 2011-11-15
UY31192A1 (es) 2009-01-30
AR067348A1 (es) 2009-10-07
WO2009006086A2 (en) 2009-01-08
CL2008001913A1 (es) 2009-01-16

Similar Documents

Publication Publication Date Title
NZ593906A (en) Gpr120 receptor agonists and uses thereof
CL2007001873A1 (es) Acido((3s))-6-((¨2,6-dimetil-4-(3-(metilsulfonil)-propoxi)bifenil-3-il)metoxi-2,3-dihidro-1-benzofuran-3-il)acetico o una sal del mismo
CL2014000384A1 (es) Compuestos fungicidas de 1-(2-(2-halo-4-(4-halogen-fenoxi)-fenil)-2-alcoxi-2-alquinil/alquenil-etil)-1h-(1,2,4) triazol sustituidos; proceso para preparar dichos compuestos; composiciones agroquímicas.
BRPI0822106A2 (pt) "processo para preparação de ácido metacrílico de alta pureza."
CL2007002956A1 (es) Compuestos derivados de 4-(2-amino-1-hidroxietil)fenol, agonistas del receptor beta2 adrenergico; composicion farmaceutica, util para el tratamiento de una enfermedad pulmonar tal como asma y epoc, glaucoma, trastornos neurologicos y cardiacos, entre
CL2007001971A1 (es) Ester isopropilico del acido 4-[5-metoxi-6-(2-metil-6-[1,2,4]triazol-1-il-piridin-3-ilamino)-pirimidin-4-iloxi]-piperidin-1-carboxilico, agonista del receptor rup3, modulador del metabolismo de glucosa; composicion farmaceutica; y uso para tratar trastornos metabolicos, como diabetes, hiperlipidemia, hiperglicemia, obesidad
WO2010025451A3 (en) 5,8-difluoro-4-(2-(4-(heteroaryloxy)-phenyl)ethylamino)quinazolines and their use as agrochemicals
AR054278A1 (es) Formas polimorficas del ester etilico del acido 3-((2-{ (4-(hexiloxicarbonilamino- imino-metil)- fenilamino)-metil} -1-metil-h-bencimidazol-5- carbonil) piridin-2-il-amino)-propionico
BRPI0814294A2 (pt) Agonistas de receptor heterocíclico ligado a n para o tratamento do diabetes e de desordens metabólicas.
PE20080186A1 (es) Derivados 4,6-disustituidos de 2-metoxi-6-etilamino-pirimidina como antagonistas del receptor de prostaglandina d2
CL2012003009A1 (es) Acido3-(((3-butil-3-etil-(metiloxi)-1-1-dioxido-5-fenil-2,3,4,5-tetrahidro-1,4benxotiazepin-8-il)-metil)-amino)-pentanodioco; composicion farmaceutica que lo comprende; y su uso en un tastorno metabolico. pct.
SI2225230T1 (sl) Trdne oblike 3-(6-(1-2,2-difluorobenzo(d)(1,3)dioxol-5-il)ciklopropan- karboksamido)-3-metilpiridin-2-il) benzojske kisline
NI201100205A (es) Sales de disacarina, ácido difumárico, acido di - 1 - hidroxi - 2 - naftoico y ácido monobenzoico del 2 - ( 4 - (( 2 - amino - 4 - metil - 6 - ( pentilamino ) pirimidin - 5 - il ) metil ) fenil ) acetato de 4 - ( dimetilamino ) butilo
EP2033688A3 (de) Oxalsäurederivate und deren Verwendung als physiologische Kühlwirkstoffe
CL2008002076A1 (es) Compuestos derivados de ariloxazoles sustituidos; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para tratar diabetes, sindrome metabolico, dislipidemias, entre otras enfermedades.
EP2116300A4 (en) CATALYST FOR THE MANUFACTURE OF AN ALCOHOL
MX2009005363A (es) Pirimidinas y su uso como antagonistas del receptor cxcr2.
CR20110554A (es) Formulaciones líquidas de sales de 1-[2-(2,4-dimetilfenilsulfanil)-fenil-piperazina
EP2124872A4 (en) COMPOSITIONS FOR IMPROVING SKIN CONDITIONING WITH ALPHA-BISABOLOL AS AN ACTIVE SUBSTANCE
IL213565A0 (en) Substituted 4-(1,2,3,4-tetrahydroisoquinolin-2-yl)-4-oxo-butyric acid amide as kcnq2/2 modulators
BRPI0920645A2 (pt) processo para a preparação de compostos de (s)-(-)-2-(n-propilamino_-5- metoxitetralma e (s)-(-)-2-(n-propilamino)-5-hidroxitetralina opticamente ativos
PE20090428A1 (es) Un nuevo procedimiento para preparar acido 2-(3-{6-[2-(2,4-diclorofenil)-etilamino]-2-metoxipirimidin-4-il}-fenil)-2-metil-propionico
CL2008003832A1 (es) Compuestos derivados del acido 2-(4-(2-(((2-cloro-fenil)sulfonil)metil)-4-(carbamoil)fenoxi)-2-fluorofenil) acetico, forma cristalina anhidra ll de un compuesto especifico; procesos de preparacion; compuestos intermediario, composicion farmaceutica; y uso en el tratamiento de enfermedades inflamatorias, tales como epoc, rinitis, asma y la dermatitis.
BRPI0810330A2 (pt) "processo para preparar l-tartarato de (r)-2-metil pirrolidina, processo para preparar 6-{4-[3-((r)-2-metil-pirrolidin-1-il)-propoxi] - fenil}-2h-piridazin-3-ona, processo para preparar d-tartarato de (s)-2-metil pirrolidina"
GB2470338B (en) Process for the preparation of 4-(4-hydroxyphenyl)butan-2-one using solid acid clay catalyst

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed